MacIntyre Ciorsti, Iwuala Chinyere, Parkash Ratika
Department of Medicine, Halifax, Queen Elizabeth II Health Sciences Center, 1796 Summer Street, Room 2501D, Halifax, NS, B3H 4S9, Canada.
Curr Treat Options Cardiovasc Med. 2018 Jul 11;20(8):63. doi: 10.1007/s11936-018-0660-9.
In this review, the challenges of managing cardiac arrhythmias and syncope in the setting of pregnancy will be discussed.
Arrhythmias in pregnancy are increasing, as diagnostic and therapeutic options have advanced and women are older at the time of gestation. Atrial fibrillation has become the most common arrhythmia in pregnancy. Inherited arrhythmia has become a more common entity, with advances in treatments and genetic testing, and require specialized treatments in pregnancy. The majority of arrhythmias in pregnancy are benign. The potential risk of increased cardiac morbidity and mortality exists for mother and fetus, especially in women with structural heart disease, which is becoming increasingly common. Early evaluation, diagnosis, and appropriate treatment are necessary to achieve optimal outcomes for both mother and fetus.
在本综述中，将讨论妊娠期间管理心律失常和晕厥的挑战。
随着诊断和治疗选择的进步以及女性妊娠时年龄增大，妊娠期间的心律失常正在增加。心房颤动已成为妊娠期间最常见的心律失常。随着治疗和基因检测的进展，遗传性心律失常已成为更常见的情况，并且在妊娠期间需要特殊治疗。妊娠期间的大多数心律失常是良性的。母亲和胎儿存在心脏发病率和死亡率增加的潜在风险，尤其是在患有结构性心脏病的女性中，这种情况正变得越来越普遍。早期评估、诊断和适当治疗对于实现母婴的最佳结局是必要的。
